Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Rlfty crawled time : 07:00 save search
Relief Therapeutics Announces that more than 400,000 of its ADRs are Currently Outstanding and that, as a Result, the Company has Achieved an Important NASDAQ Initial Listing Milestone
Published: 2023-10-10 (Crawled : 07:00) - biospace.com/
RLFTF | $1.32 11.45% 1K
|
n/a
|
| O: -1.79%
H: 0.0%
C: -0.78%
nasdaq company therapeutics milestone
Relief Therapeutics Appoints World-Renowned Gene Therapy Pioneer Guangping Gao, Ph.D. as Chair of Scientific Advisory Board
Published: 2023-04-03 (Crawled : 07:00) - biospace.com/
RLFTF | $1.32 11.45% 1K
|
n/a
|
| O: -0.44%
H: 10.62%
C: 1.77%
therapeutics therapy
Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Close of Definitive Settlement Agreements
Published: 2022-12-20 (Crawled : 07:00) - prnewswire.com
RLFTF | $1.32 11.45% 1K
|
n/a
|
| O: 0.0%
H: 13.55%
C: 0.0%
NRXP | $4.325 -11.74% -13.29% 270K
|
Manufacturing
|
| O: 0.0%
H: 14.02%
C: 6.54%
therapeutics
Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Execution of Definitive Settlement Agreements
Published: 2022-11-14 (Crawled : 07:00) - prnewswire.com
RLFTF | $1.32 11.45% 1K
|
n/a
|
| O: 1.45%
H: 0.0%
C: -3.43%
NRXP | $4.325 -11.74% -13.29% 270K
|
Manufacturing
|
| O: 0.0%
H: 0.0%
C: -9.99%
therapeutics
Relief Therapeutics Files Amendment No. 2 to its Form F-6 Registration Statement with the U.S. Securities and Exchange Commission
Published: 2022-10-25 (Crawled : 07:00) - biospace.com/
RLFTF | $1.32 11.45% 1K
|
n/a
|
| O: -1.45%
H: 6.62%
C: -4.41%
therapeutics
Evotec Enters Partnership with Hannover Medical School to Create Molecular Patient Database in Autoimmune Diseases Evotec SE announced that the Company has entered a partnership with Hannover Medical S...
Published: 2022-10-25 (Crawled : 07:00) - biospace.com/
RLFTF | $1.32 11.45% 1K
|
n/a
|
| O: -1.45%
H: 6.62%
C: -4.41%
EVO | $7.02 -3.17% -3.28% 27K
|
Manufacturing
|
| O: 2.71%
H: 3.73%
C: 3.73%
partnership molecular
Relief Therapeutics Announces Promotion of Paolo Galfetti to Chief Operating Officer
Published: 2022-10-14 (Crawled : 07:00) - biospace.com/
RLFTF | $1.32 11.45% 1K
|
n/a
|
| O: -1.03%
H: 0.0%
C: -7.99%
RLFTY | $1.4006 733.33% 100
|
n/a
|
| O: -1.66%
H: 28.45%
C: 28.45%
therapeutics
Relief Therapeutics Announces Promotion of Paolo Galfetti to Chief Operating Officer RELIEF THERAPEUTICS Holding SA, a Swiss, commercial-stage biopharmaceutical company identifying, developing and comm...
Published: 2022-10-14 (Crawled : 07:00) - biospace.com/
RLFTF | $1.32 11.45% 1K
|
n/a
|
| O: -1.03%
H: 0.0%
C: -7.99%
RLFTY | $1.4006 733.33% 100
|
n/a
|
| O: -1.66%
H: 28.45%
C: 28.45%
therapeutics
Relief Announces Exclusive Distributor for PKU GOLIKE in the U.S.
Published: 2022-10-06 (Crawled : 07:00) - biospace.com/
RLFTF | $1.32 11.45% 1K
|
n/a
|
| O: 0.0%
H: 3.75%
C: 2.39%
Relief Therapeutics Announces IRB Approval and Initiation of an Investigator Initiated Trial of Nexodyn for Epidermolysis Bullosa at Ann & Robert H. Lurie Children's Hospital of Chicago
Published: 2022-09-22 (Crawled : 07:00) - biospace.com/
RLFTF | $1.32 11.45% 1K
|
n/a
|
| O: -20.21%
H: 40.17%
C: 33.19%
trial approval therapeutics initiated
Relief Therapeutics to Participate in the 22nd Annual Biotech in Europe Forum
Published: 2022-09-12 (Crawled : 07:00) - biospace.com/
RLFTF | $1.32 11.45% 1K
|
n/a
|
| O: 8.81%
H: 0.58%
C: 0.58%
europe biotech therapeutics
Relief Therapeutics Files Registration Statement on form F-1 with the U.S. Securities and Exchange Commission
Published: 2022-08-24 (Crawled : 07:00) - biospace.com/
RLFTF | $1.32 11.45% 1K
|
n/a
|
| O: -11.47%
H: 19.27%
C: 16.28%
therapeutics
Relief Therapeutics Appoints David McCullough as Head of U.S. Market Access
Published: 2022-08-17 (Crawled : 07:00) - biospace.com/
RLFTF | $1.32 11.45% 1K
|
n/a
|
| O: -2.78%
H: 8.57%
C: 4.0%
ABT | $109.23 0.31% 0.0% 7.2M
|
Health Technology
|
| O: -0.36%
H: 0.45%
C: -0.97%
MIRM | $24.02 0.46% 220K
|
Health Technology
|
| O: 0.0%
H: 2.38%
C: -0.49%
therapeutics market
Relief Signs a Definitive Agreement to Acquire a Novel Dosage Form of an Already Approved Prescription Drug for the Treatment of PKU
Published: 2022-07-13 (Crawled : 07:00) - biospace.com/
RLFTF | $1.32 11.45% 1K
|
n/a
|
| O: -14.17%
H: 21.5%
C: 15.26%
RLFTY | $1.4006 733.33% 100
|
n/a
|
| O: -1.41%
H: 0.0%
C: 0.0%
treatment drug acquire approved agreement
Relief Reports that its U.S. Collaboration Partner has Announced an Update on Breakthrough Designation for Aviptadil
Published: 2022-06-13 (Crawled : 07:00) - biospace.com/
RLFTF | $1.32 11.45% 1K
|
n/a
|
| O: -10.92%
H: 14.19%
C: -0.32%
NRXP | $4.325 -11.74% -13.29% 270K
|
Manufacturing
|
| O: -8.21%
H: 7.26%
C: -3.08%
designation collaboration aviptadil
Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the Society for Inherited Metabolic Disorders Annual Meeting
Published: 2022-04-12 (Crawled : 07:00) - biospace.com/
RLFTF | $1.32 11.45% 1K
|
n/a
|
| O: -7.03%
H: 12.61%
C: 5.88%
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: 0.0%
H: 2.06%
C: -4.12%
acer-001 metabolic therapeutics presentation
Relief Reports Full-Year 2021 Results and Provides Corporate Update
Published: 2022-03-31 (Crawled : 07:00) - biospace.com/
RLFTF | $1.32 11.45% 1K
|
n/a
|
| O: -2.25%
H: 0.57%
C: 0.43%
RLFTY | $1.4006 733.33% 100
|
n/a
|
| O: -4.76%
H: 0.0%
C: 0.0%
NRXP | $4.325 -11.74% -13.29% 270K
|
Manufacturing
|
| O: -5.61%
H: 0.37%
C: -8.92%
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: -1.72%
H: 4.91%
C: 1.75%
results
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
BSGM | $1.52 38.18% 3.2M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
VERO | $0.829 35.9% 26.42% 120K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.